Bone Growth Stimulators Market (2023-2030)
The Bone Growth Stimulators Market is projected to reach $1.94 billion by 2030, at a CAGR of 4.9% from 2023 to 2030.
- Published
- Jan 2023
- Pages
- 185
- Format
- PDF + Excel
- Report ID
- MRHC - 10478
- Base year
- 2022
- 2030 · FORECAST
- $1.94B
- 2030
- $1.94B
- CAGR 2023–2030
- 4.9%
2022 baseline · 2023–2030 forecast at 4.9% CAGR · hover a bar for the value
Key highlights
The Bone Growth Stimulators Market is projected to reach $1.94 billion by 2030, at a CAGR of 4.9% from 2023 to 2030.
The bone growth stimulation devices segment is expected to account for the largest share of the bone growth stimulators market.
The bone growth stimulators market is segmented into spinal fusion surgeries, delayed union & non-union bone fractures, oral and maxillofacial surgeries, and other applications.
The hospitals & specialized clinics segment is expected to account for the largest share of the bone growth stimulators market.
In 2023, North America is expected to account for the largest share of the bone growth stimulators market. North America’s major market share is mainly attributed to the availability of advanced technologies and the high adoption rate of innovative products in the healthcare sector in the region.
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2022 |
| Estimated Year | 2023 |
| Forecast Period | 2023–2030 |
| Market Size (2030) | USD 1.94 billion |
| CAGR (2023–2030) | 4.9% |
| Format | PDF, Excel & Cloud Portal · 185 pages |
| Segments Covered | By Product: Combined Magnetic Field Devices (CMF), Pulsed Electromagnetic Field Devices (PEMF) · By Application: Spinal Fusion Surgeries, Delayed Union & Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Other Applications · By End User: Hospitals & Specialized Clinics, Ambulatory Surgery Centers, Other End Users |
| Countries Covered | North America (Canada, Mexico), Europe (U.K., Germany, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Latin America (Brazil) |
| Key Companies | Orthofix Medical Inc., Medtronic, plc, Stryker Corporation, Johnson Private Limited, DJO, LLC, Bioventus LLC, Arthrex GmbH, Nephew plc, ITO CO., Ltd. |
Report overview
Segments covered: product, application, end user. Regions: North America, Europe, Asia-Pacific, Latin America.
Bone growth stimulators improve the body’s bone healing process in patients undergoing bone fusion surgeries. These stimulators can be worn outside or used during implantation therapies such as Cardiac Resynchronization Therapy (CRT) and Implantable Cardioverter-Defibrillator (ICD). It can heal bone fractures by applying electrical or ultrasound waves. This non-invasive bone healing treatment method is used as an alternative to bone grafts.
The growth of this market is driven by the increasing preference for minimally invasive treatments, rising cases of bone fractures and spinal injuries, increasing geriatric population and subsequent increase in the cases of orthopedic diseases and injuries, and growing incidences of sports injuries. In addition, the growing number of hospitals and surgical centers worldwide, increasing utilization of platelet-rich plasma (PRP) in other applications, and emerging economies offer opportunities for the growth of this market.
Report infographic
Market dynamics
2 factors across 1 forceIncreasing Geriatric Population and Subsequent Increase in Orthopedic Diseases and Injuries to Drive the Demand for Bone Growth Stimulators Market
According to the United Nations Population Funds (UNFPA), the geriatric population has been growing at a faster rate in the past few years. Globally, the population aged 80 years or over is growing more rapidly than the younger population.
According to the data published by the United Nations (UN) Department of Economic and Social Affairs, the number of older people aged 65 years or over was 761 million in 2021. This number is expected to reach 1.6 billion by 2050. The number of people aged 80 years or over is growing rapidly. This growth is mainly attributed to increasing life expectancy, improvements in healthcare facilities, and declining fertility and mortality rates. According to data published by the Multidisciplinary Digital Publishing Institute (MDPI), hip fractures are expected to increase by 89% by 2025 globally compared to 2000, with nearly 800,000 fractures annually.
Furthermore, the population aged 50 and above is highly prone to orthopedic diseases, resulting in impaired posture and static & dynamic foot problems. By 2050, 130 million people will suffer from osteoarthritis worldwide, of which 40 million will be severely affected. (Source: The Modern Academic Journal Management System).
Thus, the growing geriatric population and the subsequent increase in the prevalence of orthopedic diseases are expected to drive the growth of the bone growth stimulators market during the forecast period.
Increasing Preference for Stimulation Treatments to Drive the Demand for Bone growth stimulators market
Standard bone fracture management includes stabilization of the fracture site by internal or external fixation devices, compression devices or casting. Many factors can cause delayed union or non-union; however, diagnosis of the fracture depends on the pain and motion at the fracture site. Bone healing can be induced or enhanced through bone grafting or stimulators. The preference for stimulation treatments has been increasing in the last few years to overcome the drawbacks of bone graft surgeries. Bone graft surgeries may lead to an increase in the time for treatment and healing. It increases postoperative care and the need for multiple therapies.
Furthermore, the use of bone graft surgeries increases the cost of treatment. The average price for basic augmentation for a dental bone graft was around $200 to $1,200 for a single bone graft area in 2021. The cost of auto bone graft is much higher since it has two surgical sites. Moreover, patients also need to pay additional fees for other procedures, such as hospital admission, x-rays, and anesthesia. In addition, using bone grafts increases bone morbidity and disease transfer risk and may lead to immune-mediated rejection. It increases technical difficulties and postoperative bleeding, and there is a high chance of dehydration, impairing the stability of bone repair. Hence, surgeons prefer bone growth stimulators as they are convenient, easy to use, less complicated, non-operative, non-invasive, and have no risk of immunologic complications. Additionally, bone morphogenetic proteins (BMPs) serve as an alternative to autografts in some surgeries.
Thus, to reduce the risk associated with bone graft surgeries, the adoption of bone growth stimulators is increasing, subsequently driving the market’s growth.
Table of contents
11 chapters · 90 sections · 185 pages · click to expandSegmental analysis
| Segment | Largest share (2023) | Fastest growth (2023–2030) |
|---|---|---|
| By Product | Bone growth stimulation devices | — |
| By Application | Spinal fusion surgeries | — |
| By End User | Hospitals & specialized clinics | — |
By Product
- The bone growth stimulation devices segment is expected to account for the largest share of the bone growth stimulators market.
- The large market share of this segment is attributed to the increasing prevalence of non-union bone fractures and the growing preference for non-surgical treatment procedures.
- Bone growth stimulation devices are non-invasive and help promote healing after spinal fusion fractures or surgeries.
- These devices are often used to treat non-union bone fractures.
By Application
- The bone growth stimulators market is segmented into spinal fusion surgeries, delayed union & non-union bone fractures, oral and maxillofacial surgeries, and other applications.
- The spinal fusion surgeries segment is expected to account for the largest share of the bone growth stimulators market.
- The large market share of this segment is attributed to the rise in spinal fusion surgeries, technological advancements in spinal surgery, and the high incidence rate of degenerative spinal disorders and conditions and obesity.
By End User
- The hospitals & specialized clinics segment is expected to account for the largest share of the bone growth stimulators market.
- The large market share of this segment is attributed to increasing government and private organizations’ initiatives to increase and improve hospitals and specialized clinics and the continuous increase in the number of spinal fusion and orthopedic surgeries performed in hospital settings.
Geographic analysis
North America
Largest shareIn 2023, North America is expected to account for the largest share of the bone growth stimulators market. North America’s major market share is mainly attributed to the availability of advanced technologies and the high adoption rate of innovative products in the healthcare sector in the region. Additionally, the increasing healthcare expenditures, the growing elderly population, and the rising incidence & prevalence of musculoskeletal diseases contribute to the growth of this regional market. North America to Dominate the Market in 2023
Competitive landscape
- Orthofix Medical Inc.
- Medtronic, plc
- Stryker Corporation
- Johnson Private Limited
- DJO, LLC
- Bioventus LLC
- Arthrex GmbH
- Nephew plc
- ITO CO., Ltd.
Frequently asked questions
This study covers the market size and forecasts for various bone growth stimulation devices such as external bone growth stimulators, including Capacitive Coupling (CC) Devices, Combined Magnetic Field Devices (CMF), Pulsed Electromagnetic Field Devices (PEMF), Ultrasonic Bone Growth Stimulators, Implantable Bone Growth Stimulators, Bone Morphogenetic Proteins (BMP), and Platelet-Rich Plasma (PRP).
Cite this report
Meticulous Research. (2023). Bone Growth Stimulators Market - Global Opportunity Analysis and Industry Forecast (2023-2030) (Report No. MRHC - 10478). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/bone-growth-stimulator-market-3530